Return to content in this issue

Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis

Torres Górriz MC^1,2,3, Borrás Cuartero J^3,4, Pesántez Méndez CG^1,3, Stein Coronado CI^1,3, Enrique E<sup>1,2,3

1</sup>Allergy Department, Castellón University General Hospital, Castellón, Spain
²Doctoral School, Jaume I University, Castellón de la Plana, Spain
³FISABIO Foundation Research Group
⁴Allergy Department, Castellón Provincial Hospital Consortium, Castellón, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(3) : 216-217
doi: 10.18176/jiaci.0992